ENHYPEN Cap Off Landmark Latin American & U.S. Leg Of ‘BLOOD SAGA’ World Tour

Rosa Gulliver
Aug 3
3 min read

Rosa Gulliver of TINYGMUSIC | August 3, 2026

ENHYPEN CAP OFF LANDMARK LATIN AMERICAN AND U.S. LEG OF ‘BLOOD SAGA’ WORLD TOUR

FIRST-EVER LATIN AMERICAN TOUR HIGHLIGHTED BY SOLD-OUT STADIUM SHOWS AND EXPANDED MEXICO CITY DATES

DRAWS MORE THAN 193,000 FANS ACROSS 12 SHOWS IN EIGHT CITIES

ENHYPEN successfully concluded the Latin American and U.S. leg of their ongoing world tour, ENHYPEN WORLD TOUR ‘BLOOD SAGA’ IN LATIN AMERICA & UNITED STATES, drawing more than 193,000 fans across 12 shows in eight cities.

The tour kicked off on July 4 at Nubank Parque in São Paulo, before making stops in Lima, Mexico City, Dallas, San Diego, Tacoma, Oakland and concluding on August 1 at T-Mobile Arena in Las Vegas. Marking the group's first-ever tour of Latin America, ENHYPEN sold out a 41,000-capacity stadium in São Paulo, while overwhelming demand expanded their Mexico City stop from one scheduled concert to three shows, underscoring the group's growing global popularity.

Across a 25-song setlist, ENHYPEN delivered a cinematic concert experience that seamlessly blended powerful performances with the group's signature storytelling, bringing their immersive vampire-inspired universe to life on stage. Reflecting on the tour, ENHYPEN shared, "We're incredibly grateful to ENGENEs for all the love, passion, and unforgettable memories they've given us throughout the past month." The group added, "We'll be back soon with even better music and performances."

Beyond the concert stage, ENHYPEN continued to broaden their international presence throughout the tour, appearing on Brazil's leading late-night television program The Noite com Danilo Gentili and performing at a 2026 FIFA World Cup celebration event at Campo Marte in Mexico City. The group also participated in San Diego Comic-Con 2026, where they introduced global audiences to DARK MOON, HYBE's original story inspired by ENHYPEN's narrative universe, further cementing their status as a global pop culture act.

ENHYPEN will continue the 'BLOOD SAGA' world tour with concerts in Busan on August 8 and 9, ahead of the release of their highly anticipated 8th Mini Album, THE SIN : BLISS, on August 21. The tour will then continue across Europe and the UK from February through March 2027.

About ENHYPEN

ENHYPEN have swiftly ascended to global prominence as a K-pop powerhouse, achieving record-breaking milestones since their 2020 debut. Bursting onto the scene with their debut mini-album BORDER : DAY ONE, they quickly established themselves as unrivaled storytellers, shaping a distinct conceptual identity. To date, ENHYPEN have notched six Billboard 200 Top 10 albums, MANIFESTO : DAY 1 (No. 6, 2022), DARK BLOOD (No. 4, 2023), ORANGE BLOOD (No. 4, 2023), ROMANCE : UNTOLD (No. 2, 2024), DESIRE : UNLEASH (No. 3, 2025), and THE SIN : VANISH (No. 2, 2026). Expanding their global footprint, they made a landmark U.S. stadium debut during their 2023 ‘FATE’ world tour and, in 2025, became the fastest K-pop boy group to perform at Coachella. Their 2025 ‘WALK THE LINE’ world tour marked yet another milestone, with both the U.S. and European legs selling out entirely, further cementing their status as one of the true scene-stealers of the global stage. This year, ENHYPEN continue their global ascent with ‘BLOOD SAGA,’ their largest world tour to date, marking the group's first-ever tour across Latin America before bringing their signature storytelling and electrifying performances to audiences across the U.S., Europe, Asia, and beyond.

About BELIFT LAB

BELIFT LAB is a label under HYBE, created with the goal of developing idol groups targeting the global market to drive the mainstreaming of K-POP while redefining and innovating the label business. Artists under this label include ENHYPEN (debuted in November of 2020), ILLIT (debuted in March of 2024) and EVAN (debuted in June of 2026).